- Harold Varmus - Profiles in Science Search Results

1. [Revertant DNA data] (image 3)

Format:: Still Image

2. [Revertant DNA data] (image 2)

Format:: Still Image

3. [Revertant DNA data] (image 1)

Format:: Still Image

4. [Revertant DNA data] (gel 3)

Format:: Still Image

5. [Revertant DNA data] (gel 2)

Format:: Still Image

6. [Revertant DNA data] (gel 1)

Format:: Still Image

7. Viruses as Vehicles of Genetic Change

Format:: Text

8. Viral Replication and Genetics

Format:: Text

9. Varmus's testimony before the Subcommittee on Health and Environment, Committee on Commerce, U.S. House of Representatives

Format:: Text

10. Varmus' remarks at the unveiling of his portrait at NIH

Format:: Text

11. Varmus Portrait Dedicated in Bldg. 1

Format:: Text

12. Varieties of RNA Tumor Virus-Specific DNA in Cells

Format:: Still Image

13. Using Recombinant DNA Technology to Study the Behavior of Retroviruses

Format:: Text

14. Use of MMTV-Wnt-1 Transgenic Mice for Studying the Genetic Basis of Breast Cancer

Format:: Text

15. Updated Background Information for December 2, 1998 Hearing on Stem Cell Research

Format:: Text

16. Untitled speech from talk at the 5th International Congress of Virology in Strasbourg, France

Format:: Text

17. Untitled slide

Format:: Still Image

18. UCSF's Nobels: Surprise, Satisfaction and the World Reaction . . .

Format:: Still Image

19. U.S. Public Health Service Patent and Licensing Principles

Format:: Text

20. Tumor Viruses and Oncogenes

Format:: Text

21. Tumor Viruses

Format:: Text

22. Tree Shaking and Jelly Making: Growing up with Retroviruses

Format:: Text

23. Transcript of Varmus's testimony at Congressional Hearing "Biotechnology and the Ethics of Cloning: How Far Should We Go?"

Format:: Text

24. Three Decades of Wnts: A Personal Perspective on How a Scientific Field Developed

Format:: Text

25. The src Protein Contains Multiple Domains for Specific Attachment to Membranes

Format:: Text

26. The New Era in Cancer Research

Format:: Text

27. The Molecular Genetics of Cellular Oncogenes

Format:: Text

28. The Hunting of the src and "Jumping Genes"

Format:: Text

29. Testimony of Paul Berg, PhD, to the Senate Judiciary Committee Hearing [on Human Cloning]

Format:: Text

30. Testimony of Harold Varmus, MD. . . . House Committee on Energy and Commerce and Senate Committee on Health, Education, Labor, and Pensions: "Managing Biomedical Research to Prevent and Cure Disease in the 21st Century: Matching NIH Policy with Science"

Format:: Text

31. Testimony by Harold Varmus, MD, to the Senate Judiciary Committee Hearing on Human Cloning

Format:: Text

32. Tentative Model for ASV Gene Expression

Format:: Still Image

33. Telomerase Activation in Mouse Mammary Tumors: Lack of Detectable Telomere Shortening and Evidence for Regulation of Telomerase RNA with Cell Proliferation

Format:: Text

34. Synthesis of ASV DNA - 1976 Version

Format:: Still Image

35. Status of Viral DNA in Cells Chronically Infected by RNA Tumor Viruses

Format:: Still Image

36. Statement of Harold Varmus, MD, Director, National Institutes of Health, before the Senate Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies

Format:: Text

37. Statement of Harold Varmus, MD, Director, National Institutes of Health, before the Senate Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies

Format:: Text

38. Stanford Medical School Graduation Speech

Format:: Text

39. Squirrels Have It

Format:: Text

40. Some General Comments on Cloning and the Use of the P2 Room

Format:: Text

41. Small DNA Viruses

Format:: Text

42. Shattuck Lecture - Biomedical Research Enters the Steady State

Format:: Text

43. Science and the Media

Format:: Text

44. Science Policy in the Next Forty Years

Format:: Text

45. Rous RNA 5/11

Format:: Text

46. Revitalization of the Warren G. Magnuson Clinical Center

Format:: Text

47. Retroviruses

Format:: Text

48. Restriction Endonuclease Cleavage Sites in ASV-DNA

Format:: Still Image

49. Research proposal to the American Business Cancer Research Foundation

Format:: Text

50. Report of the 3rd International Congress of Virology

Format:: Text

51. Report from Cold Spring Harbor, 1979: Viral Oncogenes (and Other Items)

Format:: Text

52. Recent Evidence for Oncogenesis by Insertion Mutagenesis and Gene Activation

Format:: Text

53. Reasons to Oppose Establishment of a National Center for Complementary and Alternative Medicine

Format:: Text

54. RNA Tumor Viruses

Format:: Text

55. Public Library of Science post

Format:: Text

56. Protocol for the Use of 32p and Other Isotopes

Format:: Text

57. Proposals for Regulation of ASV Genes

Format:: Still Image

58. Progress report from "Molecular Analysis of Retroviruses and Oncogenes" grant project

Format:: Text

59. Presidential Bioethics Advisors May Well Come Down on the Side of Federal Funding for Research on Stem Cells Derived from Embryos

Format:: Text

60. Possible Model for Viral Gene Expression in Permissive Cells

Format:: Still Image

61. Possible Model for Viral Gene Expression in Nonpermissive Cells

Format:: Still Image

62. Portrait of Harold Varmus as NIH Director

Format:: Still Image

63. Political Maneuvering around Stem Cell Research Issue

Format:: Text

64. PLoS Pronunciation and Usage Key

Format:: Text

65. Ovalbumen, 'Sarc,' and 'Viral' Genes in Chicken Chromosomes

Format:: Still Image

66. Oncogenesis without Viral Oncogenes by Avian Leukosis and Mouse Mammary Tumor Viruses

Format:: Text

67. On the Nomenclature of Viruses Associated with AIDS

Format:: Text

68. Nucleotide Sequences Related to the Transforming Gene of Avian Sarcoma Virus are Present in DNA of Uninfected Vertebrates

Format:: Text

69. Notes on Genetic Engineering Seminar

Format:: Text

70. Notes from science writers seminar

Format:: Text

71. National Institutes of Health in the Tropics

Format:: Text

72. National Institutes of Health Will Honor Clinton's Commitment to Increase Spinal Cord Injury Research

Format:: Text

73. National Institute of Arthritis and Metabolic Diseases (NIAMD) clinical investigators

Format:: Still Image

74. Naming the AIDS Virus

Format:: Text

75. NIH Plan for Research in Spinal Cord Injury and Regeneration

Format:: Text

76. NIH Director-Designate Harold Varmus with First Lady Hillary Rodham Clinton

Format:: Still Image

77. Moral and Ethical Distinctions between Deriving and Using Stem Cells for Research Dog Bioethics Advisory Commission's Deliberations

Format:: Text

78. Minutes of the NIH NCCAM Trans-Agency CAM Coordinating Committee

Format:: Text

79. Minutes of the First Meeting of the PLoS Board of Directors

Format:: Text

80. Memorandum of Understanding and Agreement: Recombinant DNA

Format:: Text

81. Memorandum from Robert J. Huebner, National Institutes of Health to Harold Varmus [regarding Varmus' manuscript on the detection of new and additional virus-specific DNA sequences in chick embryo fibroblasts after infection by RSV]

Format:: Text

82. Memorandum from Harriet Rabb to Harold Varmus [on federal funding for research involving human pluripotent stem cells]

Format:: Text

83. Memorandum from Harold Varmus to the Secretary of Health and Human Services

Format:: Text

84. Memorandum from Harold Varmus to the Grand Challenges in Global Health Scientific Advisory Board

Format:: Text

85. Memorandum from Harold Varmus to members of the human retrovirus subcommittee of the Retrovirus Study Group [with the initial set of proposals on the nomenclature of the AIDS virus]

Format:: Text

86. Memorandum from Harold Varmus to members of the human retrovirus subcommittee of the Retrovirus Study Group [on their final response on the nomenclature of the AIDS virus]

Format:: Text

87. Memorandum from Harold Varmus to members of the human retrovirus subcommittee of the Retrovirus Study Group [on the results of the initial straw poll on the nomenclature of the AIDS virus]

Format:: Text

88. Memorandum from Harold Varmus to members of the human retrovirus subcommittee of the Retrovirus Study Group [on the results of the final poll on the nomenclature of the AIDS virus]

Format:: Text

89. Memorandum from Harold Varmus to members of the human retrovirus subcommittee of the Retrovirus Study Group [on the latest status on the efforts to name the AIDS virus]

Format:: Text

90. Memorandum from Harold Varmus to members of the human retrovirus subcommittee of the Retrovirus Study Group [on the latest poll regarding the nomenclature of the AIDS virus]

Format:: Text

91. Memorandum from Harold Varmus to members of the human retrovirus subcommittee of the Retrovirus Study Group [on the initial call for proposals on the nomenclature of the AIDS virus]

Format:: Text

92. Memorandum from Harold Varmus to members of the human retrovirus subcommittee of the Retrovirus Study Group [on the final proposal to the medical journals on the nomenclature of the AIDS virus]

Format:: Text

93. Memorandum from Harold Varmus to members of the human retrovirus subcommittee of the Retrovirus Study Group [on a response to a letter from Robert Gallo]

Format:: Text

94. Memorandum from Harold Varmus to Keith Hadley, Campus Biosafety Committee, University of California, San Francisco

Format:: Text

95. Memorandum from Harold Varmus to Gladys Kist and Susan Shultz [on grant application for 1985 Hepatitis B Virus Meeting]

Format:: Text

96. Letter from the Public Library of Science [to signers of the PLoS open letter]

Format:: Text

97. Letter from the Passano Foundation to Harold Varmus and J. Michael Bishop

Format:: Text

98. Letter from Yoji Ikawa, Japanese Foundation for Cancer Research to Harold Varmus

Format:: Text

99. Letter from William S. Robinson, Stanford University Medical Center to Harold Varmus

Format:: Text

100. Letter from William A. Haseltine, Dana-Farber Cancer Institute to Harold Varmus

Format:: Text